Capital + Growth
Colorado: Rich in Opportunities
Investors Go
Inland
Investors are on to Colorado, and we have about a billion ways to prove it. With life sciences companies consistently raising more than $1 billion in annual capital for the past eight years, it’s no longer a decision between east and west.
Colorado dollars often go farther than those in New York and San Francisco, and investors are making mountain-sized bets on success.
2025 Life Sciences Fundraising Snapshot
Colorado: A Financing Epicenter
(Source: Colorado BioScience Association, 2026)
Raised in 2025
Federal Funding
Public Capital
Private Capital
State Grants
Acquisitions + Partnerships
Our Success Stories
Meet our community

Onconaut Therapeutics Advances Precision Oncology from the University of Colorado Anschutz
For Dan LaBarbera, Ph.D., founder and CEO of Onconaut Therapeutics, Colorado provides the momentum and support needed to accelerate first- and best-in-class cancer therapies rooted in decades of scientific discovery. As Professor and Director of the CU Anschutz Center for...

Colorado Innovators Shine on the Nasdaq Tower
Colorado innovators keep rising, and this month they took that momentum straight to Times Square. Three standout organizations, Biodesix, GelSana, and RenewRx, earned national visibility on the Nasdaq Tower, a vivid reminder of Colorado’s strength as a leading Hub for...

Umoja Biopharma’s Colorado Momentum
The mission-driven team at Umoja Biopharma is advancing next-generation in vivo CAR T therapies. Recently named as “Company of the Year” at Colorado BioScience Association's 22nd Annual Awards Celebration Presented by AGC Biologics, Umoja’s Colorado footprint includes the CLIMB, a...

RheumaGen Rewrites the Autoimmune Playbook
At Fitzsimons Innovation Community, RheumaGen is scaling an ambitious vision to cure autoimmune diseases at their genetic source. The company’s momentum is accelerating, fueled first by a 2023 grant from the Colorado Office of Economic Development and International Trade, followed...

Reilly Williams: Building Entirely Well, Backed by Colorado’s Health Innovation Community
When Reilly Williams founded Entirely Well, she set out to transform women’s health by developing microbiome-supportive products that prevent bacterial vaginosis (BV) and yeast infections. The company’s first product—a scientifically formulated prebiotic lubricant—fosters Lactobacilli dominance, maintains vaginal pH, and inhibits...

Hannah Gordon, Ph.D.: Fueling Enveda’s Growth with Focus and Curiosity
Hannah Gordon, Ph.D., Chief Product Officer at Enveda, relies on focus, curiosity, and clear communication to develop a robust pipeline of drug candidates at one of Colorado’s most closely watched biotech success stories. Enveda uses AI to uncover life's hidden...

CNBC Covers Record Funding in Colorado, the Hub for Health Impact
CNBC coverage highlights the growth and momentum of life sciences in Colorado, including record funding, top talent, innovative collaborations with leading academic and research institutions, and investments in lab space. Colorado Bioscience Association: Record Fundraising “Investors from Colorado as well...
Investors Choose Colorado
2025 Colorado Life Sciences Venture Capital Funding
(Source: Colorado BioScience Association )
Private Capital
Pre-Seed/Seed
Series A + B
Series C, D + Later
Let us know!
Ready to Talk
Colorado?
Contact Our Economic Development and Relocation Experts.
The information submitted through this form will be used by Colorado BioScience Association (CBSA) and Metro Denver Economic Corporation (MDEDC) for the purpose of evaluating and facilitating economic development opportunities. It will be handled with the utmost confidentiality and will not be disclosed to third parties without explicit consent.
"*" indicates required fields